Gauging Appropriate Care for Older Breast Cancer Patients
Reviewing the latest clinical management tools, Dr Arti Hurria talks about caring for the geriatric oncology patient long-term, without burning out. (Source: Medscape Oncology)
Source: Medscape Oncology - April 7, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Biomarkers to Determine Who Gets Checkpoint Inhibitors
Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors. (Source: Medscape Oncology)
Source: Medscape Oncology - April 3, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Immuno-oncology in Colorectal Cancer: A Sneak Peek
Dr David J. Kerr reviews HDAC and immune checkpoint inhibitors, therapies on the horizon for a subset of patients with colorectal cancers. (Source: Medscape Oncology)
Source: Medscape Oncology - March 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Rucaparib 'Very Active' for High-Grade Ovarian Cancer
Dr Maurie Markman reports on high response rates to rucaparib therapy for ovarian cancer and looks forward to future research efforts using this PARP inhibitor. (Source: Medscape Oncology)
Source: Medscape Oncology - March 22, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors?
Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play. (Source: Medscape Oncology)
Source: Medscape Oncology - March 20, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Rare Melanomas Prove 'Hard to Get' Using Immunotherapy
Dr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma. (Source: Medscape Oncology)
Source: Medscape Oncology - March 13, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Case Presentation or Single-Patient Trial?
Dr David Kerr views a case of engineered T cells in a CRC patient with pulmonary metastases as an example of a single-patient clinical trial, neatly illustrating the potential of precision medicine. (Source: Medscape Oncology)
Source: Medscape Oncology - March 13, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
